Familial Acute Myelogenous Leukemia: Report of Three Cases
Authors
Abstract:
Acute myelogenous leukemia (AML) is a hematological malignancy, which accounts for about 15-25% of childhood's leukemia. Genetic factor is one of the most important predisposing elements in childhood acute leukemia, especially AML. In this case report, a rare presentation of familial AML is presented in three monozygotic triplets. Two were 10 months old, and the other one was 16 months old at presentation. Chemotherapeutic regimen was administered for all three sisters with good response and success in maintaining remission.Iran J Med Sci 2006; 31(4): 228-231. Keywords ● Familial AML ● monozygotic triplets ● chemotherapy ● remission
similar resources
familial acute myelogenous leukemia: report of three cases
acute myelogenous leukemia (aml) is a hematological malignancy, which accounts for about 15-25% of childhood's leukemia. genetic factor is one of the most important predisposing elements in childhood acute leukemia, especially aml. in this case report, a rare presentation of familial aml is presented in three monozygotic triplets. two were 10 months old, and the other one was 16 months old at p...
full textAcute Myelogenous Leukemia
Acute myeloid leukemia is not a single disease but a group of neoplastic disorders. The malignant cells gradually replace, and inhibit the growth and maturation of, normal erythroid, myeloid, and megakaryocytic precursors. Included among the names for this condition are acute myelogenous leukemia, acute myelocytic leukemia, acute myeloid leukemia, acute myeloblastic leukemia, acute granulocytic...
full textAcute Myelogenous Leukemia
Documented central nervous system (CNS) involvement in acute myelogenous leukemia (AML), unlike acute lymphocytic leukemia, is relatively uncommon [1 , 2] . CNS involvement in AML is reported to occur in 6%-17% of cases [1-4]. It is expected that improvements in therapy with increased frequency of remission and prolonged survival will lead to further increases in clinical CNS involvement in AML...
full textREPORT OF FOUR CASES OF FAMILIAL IDIOPATHIC PULMONARY FIBROSIS
A 25 year old male and his 46 year old aunt presented with shortness of breath and a dramatic response to steroids. The other two patients are sisters with more advanced disease. One of these responded partially to steroids, while the other died within 4 months of treatment. The genetic basis and pathogenesis are discussed.
full textA case report of acute myelogenous leukemia with Turner Syndrome.
Turner Syndrome was diagnosed in a 45 years old female, known case of Acute Myeloid Leukaemia (AML) with maturation, on Bone Marrow biopsy. She presented with blurred vision, vertigo, exertional dyspnoea and insomnia. She did not show the typical features of Turner syndrome, but her cytogenetis confirmed the diagnosis. Bone marrow biopsy showed diffuse infiltration of blast cells with cellulari...
full textTreatment of Acute Myelogenous Leukemia
There have been significant advances in our understanding of the biology of acute myelogenous leukemia (AML), and to a lesser extent, in its treatment. Dr. Estey has provided an excellent overview of the current state of the clinical management of the disease. He has described both the standard therapeutic approaches, including allogeneic hematopoietic stem cell transplantation, as well as the ...
full textMy Resources
Journal title
volume 31 issue 4
pages -
publication date 2006-12-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023